These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12724854)

  • 21. Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs.
    Patanè S
    Int J Cardiol; 2014 Oct; 176(3):1306-8. PubMed ID: 25131921
    [No Abstract]   [Full Text] [Related]  

  • 22. 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: a novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity.
    Das U; Kawase M; Sakagami H; Ideo A; Shimada J; Molnár J; Baráth Z; Bata Z; Dimmock JR
    Bioorg Med Chem; 2007 May; 15(10):3373-80. PubMed ID: 17383883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Special Issue: New Approaches to Counteract Drug Resistance in Cancer.
    Vasconcelos MH
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28025535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.
    Yuan Y; Cai T; Xia X; Zhang R; Chiba P; Cai Y
    Drug Deliv; 2016 Nov; 23(9):3350-3357. PubMed ID: 27098896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract.
    Fong WF; Wang C; Zhu GY; Leung CH; Yang MS; Cheung HY
    Phytomedicine; 2007 Feb; 14(2-3):160-5. PubMed ID: 16713217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
    Kim MK; Kim Y; Choo H; Chong Y
    Bioorg Med Chem; 2017 Feb; 25(3):1219-1226. PubMed ID: 28043777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation strategy to overcome multi-drug resistance (MDR).
    Cho CW
    Arch Pharm Res; 2011 Apr; 34(4):511-3. PubMed ID: 21544714
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversal effect of BM-cyclin 1 on multidrug resistance in C-A120 cells.
    Wang L; Sun J; Li YQ; Chen ZS; Akiyama S; Xian LJ
    Anticancer Drugs; 2007 Oct; 18(9):1015-21. PubMed ID: 17704651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic significance of ectophosphatase inhibitors in reversal of multi-drug resistance.
    Kannan S
    Med Hypotheses; 2006; 66(5):1041-2. PubMed ID: 16446053
    [No Abstract]   [Full Text] [Related]  

  • 30. The great multidrug-resistance paradox.
    Chen VY; Rosania GR
    ACS Chem Biol; 2006 Jun; 1(5):271-3. PubMed ID: 17163753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer chemoresistance; biochemical and molecular aspects: a brief overview.
    Kachalaki S; Ebrahimi M; Mohamed Khosroshahi L; Mohammadinejad S; Baradaran B
    Eur J Pharm Sci; 2016 Jun; 89():20-30. PubMed ID: 27094906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant transporter expression does not always result in drug resistance.
    Le Large TYS; El Hassouni B; Kazemier G; Piersma SR; van Laarhoven HWM; Bijlsma MF; Jimenez CR; Giovannetti E
    Cancer Sci; 2018 Oct; 109(10):3360-3362. PubMed ID: 30195264
    [No Abstract]   [Full Text] [Related]  

  • 33. Overcoming cancer multidrug resistance by codelivery of doxorubicin and verapamil with hydrogel nanoparticles.
    Qin M; Lee YE; Ray A; Kopelman R
    Macromol Biosci; 2014 Aug; 14(8):1106-15. PubMed ID: 24771682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
    Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
    Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of multidrug resistance in the age of targeted therapy.
    Türk D; Szakács G
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer Treatment by Using Traditional Chinese Medicine: Probing Active Compounds in Anti-multidrug Resistance During Drug Therapy.
    Lou JS; Yao P; Tsim KWK
    Curr Med Chem; 2018; 25(38):5128-5141. PubMed ID: 28933300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent trends of chalcones potentialities as antiproliferative and antiresistance agents.
    Winter E; Locatelli C; Di Pietro A; Creczynski-Pasa TB
    Anticancer Agents Med Chem; 2015; 15(5):592-604. PubMed ID: 25553434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reversal effect and mechanism of lobeline on the multidrug-resistance of human breast cancer cells MCF-7/ADM].
    Chen J; Shen L; Zhou R; Yao W; Zhong M; Zhu ZH; Zeng S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):738-43. PubMed ID: 19734580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R.
    Xiao H; Xiao Q; Zhang K; Zuo X; Shrestha UK
    Ann Hematol; 2010 Apr; 89(4):399-404. PubMed ID: 19756599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
    Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
    Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.